Ftse Mib
34.766,14
1,87%
DAX
20.216,19
1,54%
S&P 500
5.975,38
0,55%
NASDAQ
19.864,98
1,24%
Bitcoin
102.207,75
3,95%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ 2seventy bio Inc (TSVT) 2seventy bio Inc (TSVT) Notizie

2seventy bio Inc

TSVT
2,64
-0,27 (-9,28%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:02:12
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/12/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202422:26EDGAR2Form 144 - Report of proposed sale of securities
20/11/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202422:50EDGAR2Form 144 - Report of proposed sale of securities
12/11/202422:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202413:00BW2seventy bio Reports Third Quarter Financial Results and..
04/11/202422:01BW2seventy bio to Report Third Quarter 2024 Financial Results..
31/10/202412:08EDGAR2Form 8-K - Current report
25/9/202412:05EDGAR2Form 8-K - Current report
25/9/202412:00BW2seventy bio Provides Update on KarMMa-9 Study and Previews..
29/8/202413:00BW2seventy bio to Participate in the 2024 Morgan Stanley..
16/8/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202423:19EDGAR2Form 144 - Report of proposed sale of securities
08/8/202422:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202413:30EDGAR2Form 8-K - Current report
07/8/202413:00BW2seventy bio Reports Second Quarter Financial Results and..
05/8/202413:00BW2seventy bio to Report Second Quarter 2024 Financial Results..
26/7/202413:16EDGAR2Form 8-K - Current report
26/6/202422:11BW2seventy bio Announces Sale of Hemophilia A Candidate and..
13/6/202400:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202400:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202400:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:26EDGAR2Form 8-K - Current report
06/6/202401:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202401:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202413:00BW2seventy bio to Participate in Upcoming Investor Conferences
17/5/202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202422:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202413:09EDGAR2Form 8-K - Current report
08/5/202413:00BW2seventy bio Reports First Quarter Financial Results and..
03/5/202413:00BW2seventy bio to Report First Quarter 2024 Financial Results..
05/4/202415:05BWU.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s..
01/4/202413:30BW2seventy bio Announces Completion of Oncology and Autoimmune..
20/3/202422:04BW2seventy bio Announces Appointments of Eli Casdin and..
15/3/202423:27BWFDA Advisory Committee Votes in Favor of Bristol Myers..
07/3/202422:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202413:03EDGAR2Form 8-K - Current report
05/3/202413:00BW2seventy bio Reports Fourth Quarter and Full Year 2023..
01/3/202413:00BW2seventy bio to Report Fourth Quarter and Full Year 2023..
05/2/202422:05BW2seventy bio to Participate in Upcoming Investor Conferences
05/2/202413:02EDGAR2Form 8-K - Current report
05/2/202412:59BWBristol Myers Squibb and 2seventy bio Share Update on U.S...
02/2/202422:54EDGAR2Form 8-K/A - Current report: [Amend]
30/1/202415:25APSBiotech Shares Soar Premarket On Sale Of R&D Assets
30/1/202413:48EDGAR2Form 8-K - Current report
30/1/202413:01BW2seventy bio Announces New Strategic Path Forward
Apertura: 2,92 Min: 2,615 Max: 2,95
Chiusura: 2,91

La tua Cronologia

NASDAQ
TSVT
2seventy bio
BIT
S29303
Societe Generale Effekten
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network